中文名 | 4-(4-氯苯基)-4-氰基-1-哌啶羧酸叔丁酯 |
---|---|
英文名 | tert-butyl 4-(4-chlorophenyl)-4-cyanopiperidine-1-carboxylate |
英文别名 | MFCD11227117 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 447.9±45.0 °C at 760 mmHg |
分子式 | C17H21ClN2O2 |
分子量 | 320.814 |
闪点 | 224.7±28.7 °C |
精确质量 | 320.129150 |
PSA | 53.33000 |
LogP | 3.28 |
蒸汽压 | 0.0±1.1 mmHg at 25°C |
折射率 | 1.559 |
储存条件 | 2-8°C,干燥密封 |
海关编码 | 2933399090 |
---|
~67% 218451-34-4 |
文献:Caldwell, John J.; Davies, Thomas G.; Donald, Alastair; McHardy, Tatiana; Rowlands, Martin G.; Aherne, G. Wynne; Hunter, Lisa K.; Taylor, Kevin; Ruddle, Ruth; Raynaud, Florence I.; Verdonk, Marcel; Workman, Paul; Garrett, Michelle D.; Collins, Ian Journal of Medicinal Chemistry, 2008 , vol. 51, # 7 p. 2147 - 2157 |
~41% 218451-34-4 |
文献:ABBOTT LABORATORIES; ABBOTT LABORATORIES TRADING (SHANGHAI) COMPANY, LTD.; WANG, Xueqing; MEYER, Michael; YAO, Betty; GUO, Tao; WEI, Guo Ping,Robert; WANG, Lijuan, Jane Patent: WO2013/10453 A1, 2013 ; Location in patent: Page/Page column 126 ; |
~% 218451-34-4 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/51290 A2, 2006 ; Location in patent: Page/Page column 120-121; 133 ; WO 2006/051290 A2 |
~% 218451-34-4 |
文献:ABBOTT LABORATORIES; ABBOTT LABORATORIES TRADING (SHANGHAI) COMPANY, LTD.; WANG, Xueqing; MEYER, Michael; YAO, Betty; GUO, Tao; WEI, Guo Ping,Robert; WANG, Lijuan, Jane Patent: WO2013/10453 A1, 2013 ; |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |